The associations with bladder cancer risk for NAT2 slow versus rapid/intermediate acetylator and GSTM1 null versus present within each THM stratum were variable and consistent with the overall elevated main effects for these genes. The gene discussed is GSTM1; the disease is urinary bladder cancer.